Lorri Cavaliere(@LorriCav) 's Twitter Profile Photo

It seems that you and a few others are hell-bent on trying to damage , as well as BrainStorm. The fact is, there are many respected doctors who DO feel confident, David Taylor. Again, NurOwn WILL further science..it just might take a different road than you are on.

account_circle
Tom Fitz 👨🏻‍💻💡🔌(@_wobblewobble) 's Twitter Profile Photo

I made this Call To Action website that notifies our representatives of the infractions that occurred during the AdComm.

It’s an easy form to fill out that emails your member of Congress and both senators & gives you further info to contact them.

justiceforals.com

account_circle
Daniel Hale(@DanielH03274759) 's Twitter Profile Photo

Colorado22yr. ALS Research shows the minute Brainstorm and NurOwn stem cells collaborate with this project these cells properly adhere and become effective in everyone. Regardless of progression. Correct the body to receive these cells from actual ALS trigger and cause. Simplify.

account_circle
Daniel Hale(@DanielH03274759) 's Twitter Profile Photo

Colorado22yr. ALS Research shows the minute Brainstorm and NurOwn stem cells collaborate with this project these cells properly adhere and become effective in everyone, from correcting the body to receive them. Regardless of progression. 90%+ recovery from ALS trigger and cause.

account_circle
Daniel Hale(@DanielH03274759) 's Twitter Profile Photo

Colorado22yr. ALS Research shows the minute Brainstorm and NurOwn stem cells collaborate with this project these cells properly adhere and become effective in everyone. Regardless of progression. Adjust the body to receive these cells from biophysics of cause. 90%+ recovery.

account_circle
Daniel Hale(@DanielH03274759) 's Twitter Profile Photo

Colorado22yr. ALS Research shows the minute Brainstorm and NurOwn stem cells collaborate with this project these cells properly adhere and become effective in everyone. Regardless of progression. Correct the body before from biophysics of ALS trigger and cause. 90%+ recovery.

account_circle
ACF Equity Research(@ACFER01) 's Twitter Profile Photo

$BCLI makes mgmt changes ahead of registrational PIIIb trial for NurOwn: (prev. CMO @ $ENVB), MD, promoted to CMO – to lead PIIIb progr. while Dr. step up from Co-CEO role to Board of Directors. $AZN $AMGN $SNY $GILD $VRTX Read our Core

account_circle
Rosie RN💕(@Rosie4212313941) 's Twitter Profile Photo

ALS Uncensored 🏴‍☠️ End ALS Now It’s not gross, please don’t feel dirty. You have every right to petition the FDA to approve your use of nurOwn. You deserve it 💯

account_circle
Tom Fitz 👨🏻‍💻💡🔌(@_wobblewobble) 's Twitter Profile Photo

It might not make much difference now but let’s try everything we can to get some justice and save NurOwn from being lost forever.

account_circle
No More Excuses ALS Watchdogs!(@als_now) 's Twitter Profile Photo

Deb Bellina So true. It will also be interesting to see the (next) excuse against approval the same orgs who regularly ask for patients' money plan to cook up when aces its Phase 3b trial. Because it will, amd they know it. No Type 1's this time.
...

account_circle
Michael Wilson(@MichaelWheelson) 's Twitter Profile Photo

Lorri Cavaliere BrainStorm David Taylor Why is it okay for some to constantly post positive spin on Nurown, but it's pathological if others post the nuance to the data? I like to see all sides of the discussion to help me see the full picture.

account_circle
AZ Latina ☮️🌊🟦(@aVoice4ALS) 's Twitter Profile Photo

Linda Hagen How is he doing now Linda Hagen?
Did he notice any changes as people in the NurOwn trial did?

The avg ALSFRS-R was 37 at baseline in the MAYO trial. COYA is hoping to start the Tegs trial sometime n 2024.

account_circle
The ReNeural Project(@ReNeural) 's Twitter Profile Photo

patient can rejoice. 6 months after striking down , FDA gives the thumbs up for a phase IIIb clinical trial

It will consist of 24 weeks of placebo-controlled tests followed by an open-label extension

via @Biospace

Research
biospace.com/article/fda-ba…

account_circle
John(@PlasteredJohn) 's Twitter Profile Photo

BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn
prnewswire.com/news-releases/…

account_circle
ALS News today(@alsnewstoday) 's Twitter Profile Photo

The developer plans to launch the trial this year in hopes of gathering the evidence necessary for NurOwn’s approval. bit.ly/3UfARnq

Disease Treatment Research

The developer plans to launch the trial this year in hopes of gathering the evidence necessary for NurOwn’s approval. bit.ly/3UfARnq 

#ALS #AmyotrophicLateralSclerosis #ALSDisease #ALSTreatment #ALSResearch
account_circle